Ivan Shevchenko Email & Phone Number

Ingelheim Am Rhein, Rhineland-Palatinate, Germany

-Identifying and evaluating disease pathway targets and innovative therapeutic approaches -Ensuring the progress through the product pipeline to advance R&D business objectives -Designing and overseeing exploratory research activities: disease characterization, target selection/engagement/validation, and drug candidate characterization/identification

Mainz, Rhineland-Palatinate, Germany

-Managing the generation of packages of documents by multifunctional teams and external service providers -Providing training and guidance on good writing practices and the structure/format requirements for regulatory documents/dossiers -Supporting R&D teams in scientific data analyses and interpretation-Writing, editing, and formatting scientific and regulatory documents for (pre-)clinical development (IB, IND/IMPD, CTP) -Preparing and editing publications in immuno-oncology

Mainz, Rhineland-Palatinate, Germany

-Supporting R&D teams in scientific data analyses and interpretation, as well as with literature and database searches -Linking preclinical research activities to clinical development. Securing a seamless and fast flow of information from the research team to the project management team, the regulatory team, and the clinical team -Representing the team in internal meetings and in the communication with external partners

Berlin, Berlin, Germany

• Assessed and edited translational and clinical studies and protocols in (immuno-)oncology• Established contact and developed fruitful cooperation with opinion leaders

Weinheim

• Initiated and managed projects to diversify journal content; assessed scientific manuscripts• Established contact and productively cooperated with renowned experts in immunology

Munich Area, Germany

• Developed a workflow for FACS-sorting and proteomic analysis of rare thymic epithelial cells

Munich Area, Germany

• Elucidated the metabolic responses of human T cells to hypertonic environments• Mentored students; supervised technical assistants; analyzed clinical samples

Houston, Texas

• Developed an assay for in vivo analysis of regulatory T cell suppressive potency • Identified a regulatory T cell subset with the strongest immune-suppressive capacity

Heidelberg Area, Germany

• Developed a strategy for targeting regulatory T cells in cancer by low-dose chemotherapy